title: Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia?
authors.affiliation: Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan. Electronic address: hamutaro1292@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: Abe
authors.affiliation: Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Kimura
authors.affiliation: Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Araoka
authors.affiliation: Department of Haematology, Toranomon Hospital, Tokyo, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Taniguchi
authors.affiliation: Department of Infectious Diseases, Toranomon Hospital, Tokyo, Japan; Okinaka Memorial Institute for Medical Research, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Yoneyama
mesh_terms: D058387:Candidemia / Q000175:diagnosis* / Q000401:mortality* / Q000473:pathology; D006801:Humans; D011379:Prognosis; D011509:Proteoglycans; D044967:Serum / Q000737:chemistry*; D016019:Survival Analysis; D047071:beta-Glucans / Q000097:blood*
chemical_list: D011509:Proteoglycans; D047071:beta-Glucans; C010770:polysaccharide-K